FUNDING·Nov 13, 2026, 10:07 AM ET·Emerging signal

Mirendil says it raised $1B to automate more of AI research

TL;DR:

  • Kleiner Perkins and Clearlake Capital jointly led Mirendil's Series A financing.
  • Mirendil announced $200 million in seed funding less than six months earlier.
  • Mirendil was founded by Anthropic alumni and is building tools intended to speed AI research while reducing human involvement.

Summary

Mirendil has secured $1 billion in Series A funding, according to the company. Kleiner Perkins and Clearlake Capital led the round less than six months after its $200 million seed announcement. Founded by Anthropic alumni, Mirendil is pursuing tools intended to accelerate AI development while reducing human involvement. The financing backs that ambition, but the supplied report offers no measured research or labor savings.

Open wsj.com in a new tab ↗
Powered by Moatly Lens

The Bigger Picture

The headline tells you what happened. Discover the facts behind it, the forces at work, the connections that matter, and what comes next.

Why This Matters

Mirendil's massive funding round signals a shift toward using AI to build AI, potentially removing the human bottleneck in model development. The startup's ability to raise a billion dollars so quickly rests on its team's pedigree and claims of near-total automation. Understanding this event is vital because it tests whether capital can turn internal productivity experiments into a new industry standard for research.

What We Actually Know

  • Mirendil closed a $1 billion Series A round led by Kleiner Perkins and Clearlake Capital to build tools that automate AI development.
  • The startup's leadership team consists of alumni from Anthropic.
  • Internal company tests suggest their AI agents generated more than 99% of the code for one of their smaller models.

How the Pieces Connect

  • The company is part of a growing trend of startups aiming to reduce the human workload required for high-level scientific and AI research.

What This Could Change

  • ScenarioIf Mirendil hits its goals, the cost and time required to train new models could drop significantly as human researchers move into oversight roles.
  • InferenceThe massive capital injection suggests investors are betting on the team's pedigree despite a lack of independent verification for their productivity claims.

Where the Story Goes Next

  • What is the current official valuation following the $1 billion Series A?
  • Will independent third parties be able to verify the 99% automated coding claim?